Biography
Dr. Chen is an expert in diabetes and cardiovascular disease. He cloned Exendin 4 (BYETTA), facilitating GLP1 drug development. He discovered the mechanisms of nitro-fatty acids, novel anti-inflammatory signaling molecules, currently in phase 2 clinical trials. Recently he embarked in successful integration of human genetic discoveries with translational research.
Condition Focus
Click any of the links in the list above to view other experts with this condition focus.
Center, Institute, and Program Affiliations
Click any of the links in the list above to view other experts with these center, institute, and program affiliations.
Career Track
Click any of the links in the list above to view other experts with this career track.